Search

San Ming R. Hui

Examiner (ID: 1844, Phone: (571)272-0626 , Office: P/1621 )

Most Active Art Unit
1627
Art Unit(s)
1629, 1617, 1621, 1627, 1628
Total Applications
2265
Issued Applications
1024
Pending Applications
278
Abandoned Applications
986

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19096294 [patent_doc_number] => 20240115521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => COMPOUNDS FOR THE TREATMENT OF MYCOBACTERIAL DISEASES [patent_app_type] => utility [patent_app_number] => 18/470317 [patent_app_country] => US [patent_app_date] => 2023-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12329 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18470317 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/470317
COMPOUNDS FOR THE TREATMENT OF MYCOBACTERIAL DISEASES Sep 18, 2023 Pending
Array ( [id] => 18893700 [patent_doc_number] => 20240009185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS [patent_app_type] => utility [patent_app_number] => 18/467705 [patent_app_country] => US [patent_app_date] => 2023-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8029 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18467705 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/467705
COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS Sep 13, 2023 Abandoned
Array ( [id] => 19279107 [patent_doc_number] => 20240215578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-04 [patent_title] => POLYSUBSTITUTED NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES, PREPARATION METHOD AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/368514 [patent_app_country] => US [patent_app_date] => 2023-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6545 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18368514 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/368514
POLYSUBSTITUTED NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES, PREPARATION METHOD AND USE THEREOF Sep 13, 2023 Pending
Array ( [id] => 19316690 [patent_doc_number] => 20240238230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-18 [patent_title] => METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/463873 [patent_app_country] => US [patent_app_date] => 2023-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17784 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18463873 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/463873
METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF Sep 7, 2023 Pending
Array ( [id] => 18860184 [patent_doc_number] => 20230414618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => Methods of Administering Elagolix [patent_app_type] => utility [patent_app_number] => 18/462054 [patent_app_country] => US [patent_app_date] => 2023-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15404 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18462054 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/462054
Methods of Administering Elagolix Sep 5, 2023 Abandoned
Array ( [id] => 18860161 [patent_doc_number] => 20230414595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => EMULSIONS FOR LOCAL ANESTHETICS [patent_app_type] => utility [patent_app_number] => 18/462162 [patent_app_country] => US [patent_app_date] => 2023-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23871 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18462162 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/462162
EMULSIONS FOR LOCAL ANESTHETICS Sep 5, 2023 Pending
Array ( [id] => 18901315 [patent_doc_number] => 20240016800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-18 [patent_title] => METHODS OF TREATING NEUROFIBROMATOSIS WITH PERILLYL ALCOHOL [patent_app_type] => utility [patent_app_number] => 18/461562 [patent_app_country] => US [patent_app_date] => 2023-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18369 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18461562 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/461562
METHODS OF TREATING NEUROFIBROMATOSIS WITH PERILLYL ALCOHOL Sep 5, 2023 Pending
Array ( [id] => 20802673 [patent_doc_number] => 12667561 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-06-30 [patent_title] => Gel containing pirfenidone [patent_app_type] => utility [patent_app_number] => 18/458390 [patent_app_country] => US [patent_app_date] => 2023-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18458390 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/458390
Gel containing pirfenidone Aug 29, 2023 Issued
Array ( [id] => 18815879 [patent_doc_number] => 20230390218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-07 [patent_title] => EPINEPHRINE SPRAY FORMULATIONS [patent_app_type] => utility [patent_app_number] => 18/453360 [patent_app_country] => US [patent_app_date] => 2023-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19306 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18453360 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/453360
EPINEPHRINE SPRAY FORMULATIONS Aug 21, 2023 Pending
Array ( [id] => 19170862 [patent_doc_number] => 20240156836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-16 [patent_title] => METHODS OF TREATING TESTOSTERONE DEFICIENCY [patent_app_type] => utility [patent_app_number] => 18/451557 [patent_app_country] => US [patent_app_date] => 2023-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12257 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18451557 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/451557
METHODS OF TREATING TESTOSTERONE DEFICIENCY Aug 16, 2023 Pending
Array ( [id] => 18986369 [patent_doc_number] => 20240058338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-22 [patent_title] => COMBINATION OF RAF INHIBITOR AND MEK INHIBITOR [patent_app_type] => utility [patent_app_number] => 18/450638 [patent_app_country] => US [patent_app_date] => 2023-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30086 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18450638 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/450638
COMBINATION OF RAF INHIBITOR AND MEK INHIBITOR Aug 15, 2023 Pending
18/234232 METHODS AND COMPOSITIONS FOR REDUCING SYMPTOMS OF PARKINSON'S DISEASE Aug 14, 2023 Abandoned
Array ( [id] => 18815949 [patent_doc_number] => 20230390288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-07 [patent_title] => SOLID DOSE PHARMACEUTICAL COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/447892 [patent_app_country] => US [patent_app_date] => 2023-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27083 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -77 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18447892 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/447892
SOLID DOSE PHARMACEUTICAL COMPOSITION Aug 9, 2023 Abandoned
Array ( [id] => 19768333 [patent_doc_number] => 20250049759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-13 [patent_title] => PHARMACEUTICAL PREPARATION FOR ASSISTING IN PROMOTING SLEEP AND PREPARATION METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 18/230749 [patent_app_country] => US [patent_app_date] => 2023-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3160 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18230749 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/230749
PHARMACEUTICAL PREPARATION FOR ASSISTING IN PROMOTING SLEEP AND PREPARATION METHOD THEREOF Aug 6, 2023 Pending
Array ( [id] => 19216209 [patent_doc_number] => 20240180913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-06 [patent_title] => THE THERAPEUTIC REGIMEN [patent_app_type] => utility [patent_app_number] => 18/219507 [patent_app_country] => US [patent_app_date] => 2023-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10243 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18219507 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/219507
Therapeutic regimen Jul 6, 2023 Issued
Array ( [id] => 18877359 [patent_doc_number] => 20240000728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-04 [patent_title] => ESKETAMINE FOR THE TREATMENT OF DEPRESSION [patent_app_type] => utility [patent_app_number] => 18/347393 [patent_app_country] => US [patent_app_date] => 2023-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 115855 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 202 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18347393 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/347393
ESKETAMINE FOR THE TREATMENT OF DEPRESSION Jul 4, 2023 Abandoned
Array ( [id] => 19156022 [patent_doc_number] => 20240148729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-09 [patent_title] => LOPINAVIR AND RITONAVIR FOR THE TREATMENT OF CERVIX DISORDERS [patent_app_type] => utility [patent_app_number] => 18/216937 [patent_app_country] => US [patent_app_date] => 2023-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19028 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18216937 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/216937
Lopinavir and ritonavir for the treatment of cervix disorders Jun 29, 2023 Issued
Array ( [id] => 18707472 [patent_doc_number] => 20230330046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => TARGETING OCULAR DISEASES WITH NOVEL APE1/REF-1 INHIBITORS [patent_app_type] => utility [patent_app_number] => 18/341077 [patent_app_country] => US [patent_app_date] => 2023-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9691 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18341077 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/341077
TARGETING OCULAR DISEASES WITH NOVEL APE1/REF-1 INHIBITORS Jun 25, 2023 Abandoned
Array ( [id] => 19402071 [patent_doc_number] => 20240285582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE [patent_app_type] => utility [patent_app_number] => 18/340067 [patent_app_country] => US [patent_app_date] => 2023-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10856 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18340067 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/340067
Stable pharmaceutical compositions of edaravone Jun 22, 2023 Issued
Array ( [id] => 18707532 [patent_doc_number] => 20230330108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => MULTIPHASIC CONTRACEPTIVE REGIMEN FOR ORAL COMBINATION DRUG FORMULATION OF PROGESTIN AND ESTROGEN [patent_app_type] => utility [patent_app_number] => 18/336476 [patent_app_country] => US [patent_app_date] => 2023-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6388 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 259 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18336476 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/336476
Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen Jun 15, 2023 Issued
Menu